Inauguration of Predictmedix’ Safe Entry Station at Indian Oil Corporation Limited (IOCL) - June 28/2021
posted on
Jun 30, 2021 08:30AM
Revolutionizes Health Screening with 95% Accuracy
Hot off the press circuit from Monday’s event …
Inauguration of Predictmedix’ Safe Entry Station at Indian Oil Corporation Limited (IOCL) by the Director on June 28/2021 in New Delhi, India.
quote: “We’ve very happy to announce successfully we’ve been deploying more and more units out of India … very excited, looking for more and more units.”
Youtube video link --> https://youtu.be/96m4yxr7jTo
Signage of Inauguration of Predictmedix’ Safe Entry Station at Indian Oil Corporation (IOCL) in New Delhi, India.
Youtube video link--> https://youtu.be/q30SeQFeLQE
I’ll post more video from this event including an interview with Indian Oil Corporation’s (a multi-billion $ publicly traded company) Vice President stating how they were initially skeptical of this new AI technology but are now extremely pleased with the Predictmedix Safe Entry Station and the office where this unit has been installed has been flagging 1-3 cases/month of entrants with COVID-19 symptoms.
For more information please visit https://getsafeentry.com/
and https://www.instagram.com/getsafeentry/
and https://www.instagram.com/predictmedix/
and https://www.instagram.com/indianoilcorp/
Predictmedix Inc. trades as “PMED” on the Canadian Securities Exchange and “PMEDF” on the OTCQB market in the United States.
About Predictmedix Inc.
Predictmedix (CSE: PMED | OTCQB: PMEDF) is a Life Sciences technology company developing AI-powered products to
improve workplace health and safety, enhance protection in public environments, and provide tools for medical professionals to better care for patients. Our symptom detection products use non-invasive technologies to capture data points from each person walking through our Safe Entry screening units. Within seconds, our products determine if individuals are displaying symptoms of infectious disease, such as Covid-19, or are exhibiting signs of impairment from alcohol or cannabis. Our new AI products in development will give medical professionals tools that empower their decision making for better patient outcomes.